Kinnate Biopharma (KNTE) PT Raised to $50 at Wedbush

May 18, 2021 6:51 AM EDT
Get Alerts KNTE Hot Sheet
Price: $21.87 -0.09%

Rating Summary:
    5 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 18 | Down: 11 | New: 19
Trade Now! 
Join SI Premium – FREE
Wedbush analyst David Nierengarten raised the price target on Kinnate Biopharma (NASDAQ: KNTE) to $50.00 (from $48.00) while maintaining a Outperform rating.

You May Also Be Interested In





Related Categories

Analyst PT Change